ALIMA & Gilead Sciences

ALIMA: ALIMA's Ebola treatment tents were set on fire during unrest, highlighting the tensions and security challenges faced by aid groups in the affected regions.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

ALIMA: ALIMA set up isolation tents in Democratic Republic of the Congo — Ituri Province, which were later set on fire by an angry crowd, complicating the Ebola response efforts.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.

ALIMA: ALIMA is a medical charity whose tents were set on fire by protesters in Ituri, highlighting the challenges faced by aid workers.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.